Oragenics Inc (OGEN)
1.03
-0.03
(-2.83%)
USD |
NYAM |
Apr 26, 16:00
1.05
+0.02
(+1.94%)
Pre-Market: 20:00
Oragenics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2015 | -355.4% |
| December 31, 2014 | -554.9% |
| September 30, 2014 | -512.2% |
| June 30, 2014 | -624.0% |
| March 31, 2014 | -764.4% |
| December 31, 2013 | -708.2% |
| September 30, 2013 | -3.68K% |
| June 30, 2013 | -1.24K% |
| March 31, 2013 | -901.3% |
| December 31, 2012 | -461.9% |
| September 30, 2012 | -967.3% |
| June 30, 2012 | -2.70K% |
| March 31, 2012 | -424.9% |
| December 31, 2011 | -489.0% |
| September 30, 2011 | -515.9% |
| June 30, 2011 | -682.8% |
| March 31, 2011 | -445.5% |
| December 31, 2010 | -728.6% |
| September 30, 2010 | -514.4% |
| June 30, 2010 | -659.7% |
| March 31, 2010 | -511.7% |
| December 31, 2009 | -447.6% |
| Date | Value |
|---|---|
| September 30, 2009 | -719.7% |
| June 30, 2009 | -2.07K% |
| March 31, 2009 | -1.59K% |
| December 31, 2008 | -35.10K% |
| September 30, 2008 | -1.14K% |
| June 30, 2008 | |
| March 31, 2008 | -633.3% |
| December 31, 2007 | -2.57K% |
| September 30, 2007 | -1.05K% |
| June 30, 2007 | -2.22K% |
| March 31, 2007 | -1.64K% |
| December 31, 2006 | |
| September 30, 2006 | -845.0% |
| June 30, 2006 | |
| March 31, 2006 | |
| December 31, 2005 | |
| September 30, 2005 | |
| June 30, 2005 | |
| March 31, 2005 | |
| December 31, 2004 | -3.78K% |
| September 30, 2004 | -517.3% |
| June 30, 2004 | -1.51K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Palatin Technologies Inc | -385.6% |
| Inogen Inc | -34.99% |
| Cyclacel Pharmaceuticals Inc | -17.00K% |
| Actinium Pharmaceuticals Inc | -11.51K% |
| MAIA Biotechnology Inc | -- |